Loading...
Found 43 Lymphoma trials
A listing of Lymphoma medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Sort by:
- Sort by
- Last updated
The purpose of this trial is to evaluate the safety and efficacy of 18 weeks of HyBryte treatment in combination with visible light therapy in subjects 18 years and older with cutaneous T-cell lymphoma when compared to placebo. Procedures include vital signs, physical examination, review of medical history, blood tests, …
This is a retrospective chart review study assessing real-world treatment patterns and outcomes in patients with cutaneous T-cell lymphoma (CTCL) treated with extracorporeal photopheresis (ECP), interferons, and/or bexarotene. De-identified data will be abstracted from existing medical records to evaluate demographics, treatment sequences, and clinical responses in adult patients with MF …
This study investigates providing access to axicabtagene ciloleucel, an investigational medication, for patients who have a disease approved for treatment with this medication but whose product does not meet commercial release criteria. The purpose is to allow patients to receive treatment with axicabtagene ciloleucel that is otherwise unavailable due to …
This study investigates the safety and anti-cancer activity of an investigational medication in adults with advanced B-cell malignancies. These conditions include Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Diffuse Large B-cell Lymphoma (DLBCL), Mantle Cell Lymphoma (MCL), Waldenstrom Macroglobulinemia (WM), Marginal Zone Lymphoma (MZL), Follicular Lymphoma (FL), Primary Central …
This study investigates the use of an investigational therapy for patients who have been diagnosed with a condition approved for treatment with this therapy, but whose therapy does not meet commercial release criteria. The purpose is to provide access to this investigational treatment under specific conditions.Participants in this study will …
This study investigates the safety and efficacy of an investigational medication, surovatamig, administered alone or with other anticancer agents in individuals with mature B-cell malignancies. This study is open-label, meaning both researchers and participants know what treatment is being administered. It includes three substudies, each focusing on different types of …
This study investigates the safety and appropriate dosing of investigational cells in patients with T Cell Non-Hodgkin Lymphoma. The purpose of this study is to determine how well these cells can be tolerated by patients and to identify the best dose for future studies. The focus is on patients whose …
This study investigates the effects of adding investigational medications to the usual chemotherapy regimen for patients with peripheral T-cell lymphoma. The purpose of this study is to compare the effectiveness of three different treatment arms: one with the investigational medication duvelisib, another with the investigational medication CC-486, and the third …
This study investigates the use of an investigational medication, a monoclonal antibody targeting Tumor Necrosis Factor Receptor 2 (TNFR2), in people with advanced malignancies. The purpose of the study is to evaluate the safety and tolerability of the investigational medication both alone and in combination with pembrolizumab, a type of …
This study investigates the safety and effectiveness of an investigational medication in patients with advanced blood cancers, including Non-Hodgkin Lymphoma, Multiple Myeloma, Acute Myeloid Leukemia, and high-risk Myelodysplastic Syndrome.Participants in the study will receive the investigational medication either alone or in combination with other treatments. The study will monitor the …
Please choose between Voice or SMS based delivery of verification code
or